SlideShare a Scribd company logo
1 of 67
CHAIRPERSON – DR. SANJEEV KUMAR
SPEAKER - DR. ASHISH KUMAR
DEFINITION
 AKI is a sudden and usually reversible decrease
in the glomerular filtration rate (GFR) occurring
over a period of hours to days.
 The term “Acute Kidney Injury” now replaces
the term ARF; the term Acute Renal Failure
should now be restricted to patients who have
AKI and “need renal replacement therapy”.
‘ACUTE KIDNEY INJURY’
Abrupt reduction [<48 hrs] in kidney
function, defined as an absolute increase in S
creatinine of ≥0.3 mg/dL
A percentage increase in S creatinine of ≥ 50%
[1.5 fold from baseline] or
a reduction in urine output-- documented
oliguria of < 0.5 ml/kg/hr, for more than six
hours.
Hilton, R. BMJ 2006;333:786-790
CAUSES OF ACUTE KIDNEY INJURY
AKI
Pre-renal causes of AKI
– Volume depletion
• Renal losses (diuretics, polyuria)
• GI losses (vomiting, diarrhea)
• Cutaneous losses (burns, Stevens-Johnson syndrome)
• Hemorrhage
• Pancreatitis
– Decreased cardiac output
• Heart failure
• Pulmonary embolus
• Acute myocardial infarction
• Severe valvular heart disease
Post-renal causes of AKI
– Ureteric obstruction
• Stone disease,
• Tumor,
• Fibrosis,
• Ligation during pelvic surgery
– Bladder neck obstruction
• Benign prostatic hypertrophy [BPH]
• Cancer of the prostate
• Neurogenic bladder
• Drugs(Tricyclic antidepressants, ganglion blockers,
• Bladder tumor,
• Stone disease, hemorrhage/clot)
– Urethral obstruction (strictures, tumor)
Renal Causes of AKI
• Large Vascular
• Small vascular and Glomerular
• Interstitial nephritis
• Acute tubular necrosis
Renal Causes of AKI
• Large Vascular
• Renovasc disease + ACEI
• Renal artery thrombosis/dissection
• Cholersterol emboli (recent Cardiac cath/aortic
surgery)
• Renal vein Thrombosis (hypercoagulable,
Nephrotic)
• Acute Glomerulonephritis (GN) / Small
vascular
• Anti–glomerular basement membrane (GBM)
disease (Goodpasture syndrome)
• Anti–neutrophil cytoplasmic antibody-associated
glomerulonephritis (ANCA-associated GN)
(Wegener granulomatosis, microscopic polyangiitis)
• Immune complex GN (lupus, postinfectious,
cryoglobulinemia, primary membranoproliferative
glomerulonephritis)
• IgA nephropathy
• HUS/TTP
• Malignant hypertension
• Tubular
• Ischemic
• Toxic
– Heme pigment (rhabdomyolysis, intravascular
hemolysis)
– Crystals (tumor lysis syndrome, seizures, ethylene
glycol poisoning, megadose vitamin C, acyclovir,
indinavir, methotrexate)
– Drugs (aminoglycosides, lithium, amphotericin B,
pentamidine, cisplatin, ifosfamide, radiocontrast
agents)
• Interstitial
• Drugs (penicillins, cephalosporins, NSAIDs,
proton-pump inhibitors, allopurinol, rifampin,
indinavir, mesalamine, sulfonamides)
• Infection (pyelonephritis, viral nephritis)
• Systemic disease (Sjogren syndrome, sarcoid,
lupus, lymphoma, leukemia )
Pre-renal AKI
• History
-- blood or volume loss
-- cardiac failure, arrhythmia,
(cardiogenic shock)
-- sepsis
• Physical exam – focus on volume status
– Vital signs – current and preceding the
development of AKI
– Neck veins, lungs, heart, mucous membranes and
edema
Pre-renal AKI
• There is no intrinsic kidney damage in
pre-renal AKI; rising BUN and creat occur
because the kidneys are inadequately
perfused.
• Therefore, normal renal physiologic
responses occur, manifested in urine
electrolytes that reflect intact renal
tubular function.
Pre-renal AKI
• Intact renal tubular function in the
setting of impaired renal perfusion
results in avid tubular reabsorption of
sodium.
• Therefore, low urine Na (<20 mEq/L)
and low fractional excretion of Na
(<1%) and of urea (<35%) in pre-renal
ARF.
Pre-renal AKI
• Laboratory studies
– BUN:creatinine ratio – elevated in pre-renal; >20:1
– Urine sediment: hyaline and fine granular casts
– Urine Specific gravity: high
– Urine dipstick: negative (no blood or protein)
– Urinary to plasma creatinine ratio: high
– Urinary Na: low
– FENa: low
• Sustained prerenal azotemia is the main factor
that predisposes patients to ischemia- induced
acute tubular necrosis (ATN)
• Prerenal azotemia and ischemic tubular necrosis
represent a continuum. Azotemia progresses to
necrosis when blood flow is sufficiently
compromised to result in the death of tubular
cells.
• Most cases of ischemic AKI are reversible if the
underlying cause is corrected.
Renal or Intrinsic AKI
• In all types of intrinsic AKI, BUN:creat
ratio preserved (10-20:1)
• The history, P/E, and especially urine
analysis will help to differentiate
Renal or Intrinsic ARF
– Vascular Type
• Large vessels – must be bilateral
– Renal vein thrombosis
– Renal artery stenosis
• Small vessels
– Vasculitis
– Atheroembolic
– Malignant hypertension
– Thrombotic microangiopathies (HUS/TTP)
Renal or Intrinsic AKI
– Glomerular
• History – systemic or primary kidney
• P/E – BP (usually hypertensive)
-- edema
• BUN:creatinine ratio: preserved
• Urine analysis : + protein, blood
RBCs,+
• Often require kidney biopsy
RBC Casts
Renal or Intrinsic AKI
– Interstitial
• History – exposure to medications usually 7-
14 days earlier
-- penicillins, cephalosporins, dilantin
• P/E – maculopapular erythematous skin rash
-- 1/3 have fever, arthralgias
• BUN:creatinine ratio: 10-20:1
• Urine analysis: + protein, blood
WBCs, WBC casts, eosinophils
Renal or Intrinsic
ATN – Acute Tubular Necrosis
• The most common type of hospital-acquired
ARF
• May be
1) ischemic or
2) nephrotoxic in etiology
• Most common ATN is ischemic, most often due
to a prolonged pre-renal state (prolonged
reduced renal perfusion)
Renal or Intrinsic
ATN – Acute Tubular Necrosis
• History – prolonged pre-renal state
-- exposure to nephrotoxin
aminoglycoside antibiotics
ethylene glycol
pigments (myoglobin, hemoglobin)
• P/E – assess volume status (to exclude pre-
renal AKI)
Renal or Intrinsic
ATN – Acute Tubular Necrosis
• BUN:creatinine ratio: preserved (10-20:1)
• Urine analysis : negative protein, blood
-- granular casts (dirty brown casts)
-- renal tubular epithelial cells
• Urine chemistries – Urinary Na: high (>40 meq/L)
FENa: high (>2%)
Urinary to plasma creatinine ratio: low
Contrast-Induced AKI
Prevalence
• Less than 1% in patients with normal renal
function
• Increases significantly with renal insufficiency
Risk factors
• Renal insufficiency
• Diabetes mellitus
• Multiple myeloma
• High osmolar (ionic) contrast media
• Contrast medium volume
Contrast-induced AKI
Clinical Characteristics
• Onset - 24 to 48 hrs after exposure
• Duration - 5 to 7 days
• Non-oliguric (majority)
• Dialysis - rarely needed
• Urinary sediment - variable
• FENa: Low
Contrast-induced AKI
Prophylatic Strategies
• Use I.V. contrast only when necessary
• Hydration
• Minimize contrast volume
• Low-osmolar (nonionic) contrast media
Post-Renal AKI
• Elevated pressure in urinary conduits results in
renal parenchymal destruction if unrelieved
• important to rule out quickly:
– potential for recovery of renal function is
often inversely related to the duration of the
obstruction
Post-Renal AKI
• History – symptoms (frequency, hesitancy, etc)
-- carcinoma, DM, stones, medications
• P/E – distended bladder, prostatic enlargement, pelvic
masses , lymph nodes
• Laboratory studies-- elevated BUN:creat ratio
-- unremarkable urine sediment
-- variable urine chemistries
• Renal ultrasound – hydronephrosis
• Treatment is to relieve the obstruction
– Bladder catheterization
– Nephrostomy tubes
AKI: URINE VOLUME
• Anuria (< 100 ml/24h)
– Acute bilateral arterial or venous occlusion
– Bilateral cortical necrosis
– Acute necrotizing glomerulonephritis
– Obstruction (complete)
– ATN (very rare)
• Oliguria (100-500 ml/24h)
– Pre-renal azotemia
– ATN
• Non-Oliguria (> 500 ml/24h)
– ATN
– Obstruction (partial)
INVESTIGATIONS
Biochemistry
 Blood urea,
 creatinine,
 electrolytes,
 Blood gas analysis.
 Urine osmolality/sodium/creatinine
Serum Creatinine as a marker
for AKI and GFR
 Normal S.Creatinine is 0.6-1.2mg/dl and is the
most commonly used parameter to assess renal
function.
 Unfortunately the correlation between
S.Creatinine concentration and GFR may be
confounded by several factors.
There is abrupt drop in GFR but the S.Cr. does not start going up for
24 or 36 hours after the acute insult .
40
80
0
GFR
(mL/min)
0 7 14 21 28
4
Days
2
0
6
Serum
Creatinine
(mg/dL)
Relationship between GFR and serum creatinine in
AKI
Creatinine is not an ideal marker
1.Creatinine excretion is dependent on renal factors
independent of function:
– Certain medications such as cimetidine and
trimethoprim interfere with proximal tubular
creatinine secretion and may cause rise in S.
creatinine without fall in GFR.
2. S.Creatinine is dependent on nonrenal factors
independent of renal function
 S.Creatinine is dependent on muscle mass,
infection, volume of distribution, age, gender, race,
body habitus, diet, presence of amputations.
 Eg. S. Creatinine of 1.2mg/dl in a 40kg elderly
signifies severe reduction of GFR while the same
value in a 100kg represents a normal renal function
3. Creatinine production and excretion must be in a
steady state before creatinine may be used in any
formula for the estimation of GFR.
Fractional Excretion of Na
• Since urinary indices depend on urine sodium
concentration, they should be interpreted cautiously if the
patient has received diuretic
 Spot urine Na may be affected (raised) by diuretic use and
baseline impaired kidney function (CKD where maximum
urine Na reabsorption is impaired)
 Fractional excretion of Na accounts for this by including
creatinine:
FxExNa = urine [Na] ÷ plasma [Na] X 100
urine creatinine ÷ plasma creatinine
RENAL INDICES
• Renal Failure Index (RFI)
RFI = urine [Na]
urine creatinine /serum creatinine
URINE AND SERUM
LABORATORY VALUES
Prenal Renal
BUN/Cr >20 <20
FeNa <1% >1%
RFI <1% >1%
UNa (mEq/L) <20 > 40
Specific gravity high low
Pre-renal
URINE ANALYSIS
• Dipstick for blood, protein – Suggests a
renal inflammatory process
• Microscopy may show cells, casts, crystals
RBCs in Urine
Present in
glomerulonephritis ,
vasculitis ,
HUS TTP
scleroderma crisis
URINARY CASTS
 Hyaline –prerenal ARF
 Granular –ATN (muddy brown)
 Red blood cell casts –glomerulonephritis,vasculitis
malignant hypertension
 WBC casts- AIN, pyelonephritis ,leukemic or
lymphomatous infiltrates
Red Blood Cell Cast
• Two examples of
red blood cell
casts, typical of
glomerular
bleeding.
White Blood Cell Cast
Pigmented Granular Casts
• Pigmented
granular (“muddy
brown”) casts are
characteristic of
acute tubular
necrosis
Crystals
• Urate crystals – acute urate nephropathy
• Oxalate crystals –ethylene glycol ingestion
/acyclovir/ indinavir
• Eosinophiluria  > 5 % of WBC s
AIN ,atherothrombotic
disease
Haematology
• Full blood count, blood film:
– Eosinophilia may be present in acute interstitial
nephritis,
cholesterol embolization, or vasculitis (CSS)
– Thrombocytopenia and red cell fragments suggest
thrombotic microangiopathy –TTP, HUS
• Coagulation studies
– Disseminated intravascular coagulation associated
with sepsis
Immunology
 Antinuclear antibody (ANA) , Anti-double stranded
(ds) antibody -
 ANA positive in SLE and other autoimmune
disorders;DNA antibodies anti-ds DNA antibodies
more specific for SLE
 C3 & C4 complement concentrations-
 Low in SLE, acute post infectious
glomerulonephritis, Cryoglobulinemia
 ASO and anti-DNAse B titres
 High after streptococcal infection
Immunology...
• ANCA
• p-ANCA - Anti PR3 antibodies
• c-ANCA - Anti MPO antibodies
– Associated with systemic vasculitis - Wegener’s
granulomatosis; Microscopic polyangiitis.
• AntiGBM antibodies
– Present in Goodpasture’s disease
Serology
• Hepatitis B and C, HIV serology
Radiology
• Renal ultrasonography : For renal size,
symmetry, evidence of obstruction
• Pyelography : localization
• MRA/ Doppler US : arterial /venous
obstruction
NEW MARKER
• Cystatin C –protein
Produced by nucleated cells
Filtered and completely reabsorbed
Changes in serum levels occur sooner
NOVEL BIOMARKERS
• 1. IL- 18
• 2.KIM-1
• 3.Gro α/KC
• 4.NGAL-neutrophil gelatinase associated lipocalin
• 5.NHE-3 -Sodium–hydrogen antiporter 3
Complications
Complications
Complications
Other Complications
Hyperuricemia
Infection- pneumonia, sepsis
Git- nausea, vomiting, malnutrition, git bleeding
CNS- asterixis, mental changes, seizures
Uremic syndrome
AKI: PREVENTION
Recognize patients at risk (postoperative
states, cardiac surgery, septic shock)
Prevent progression from prerenal to renal
Preserve renal perfusion(isovolemia, cardiac
output, normal blood pressure)
Avoid nephrotoxins (aminoglycosides,
NSAIDS, amphotericin)
GENERAL PROTOCOL FOR
MANAGEMENT OF AKI
• Treat the underlying disease
• Strictly monitor intake and output (weight,
urine output, insensible losses, IVF)
• Monitor serum electrolytes
• Adjust medication dosages according to GFR
• Avoid highly nephrotoxic drugs
• Attempt to convert oliguric to non-oliguric
renal failure (furosemide)
FLUID THERAPY
If patient is fluid overloaded
• fluid restriction (insensible losses)
• attempt furosemide 1-2 mg/kg
• Renal replacement therapy
If patient is dehydrated:
• restore intravascular volume first
• then treat as euvolemic
If patient is euvolemic:
• restrict to insensible losses (30-35 ml/100kcal/24 hours) +
other losses (urine, chest tubes, etc)
SODIUM
• Most patients have dilutional hyponatremia
which should be treated with fluid restriction
• Severe hyponatremia (Na< 125 mEq/L) : dialysis
or hemofiltration
POTASSIUM
• Oliguric renal failure is often complicated by
hyperkalemia, increasing the risk of cardiac
arrhythmias
• Treatment of hyperkalemia:
– sodium bicarbonate (1-2 mEq/kg)
– insulin + hypertonic dextrose
– sodium polystyrene : 1 gm/kg .
(Hypernatremia and hypertension are
potential complications)
– dialysis
MANAGEMENT OF AKI
 Metabolic acidosis – soda bicarb ., if < 15 meq
 Hyperphosphatemia – PO4 binders –sevalamer
 Hypocalcemia –calcium carbonate
 Nutrition –restriction of dietary protein < 0.8 g/kg /d
calories – 25-30 kcal /kg/d
enteral nutrition preferred
Criteria for Initiation of RRT
Anuria
Oliguria
Pulmonary edema
Hyperkalemia >6.5mmol/L
Severe acidemia <7.2
Uremic encephalopathy
Uremic pericarditis
Thank
you

More Related Content

What's hot

Acute renal failure
Acute renal failure Acute renal failure
Acute renal failure Leena Hafeez
 
Pathophysiology of liver cirrhosis and alcholoic liver disease
Pathophysiology of liver cirrhosis and alcholoic liver diseasePathophysiology of liver cirrhosis and alcholoic liver disease
Pathophysiology of liver cirrhosis and alcholoic liver diseaseKoppala RVS Chaitanya
 
Acute kidney injury defnition, causes,
Acute kidney injury   defnition, causes,Acute kidney injury   defnition, causes,
Acute kidney injury defnition, causes,PGIMER,DR.RML HOSPITAL
 
ACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENTACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENTRajee Ravindran
 
ACUTE KIDNEY INJURY / ACUTE RENAL FAILURE
ACUTE KIDNEY INJURY / ACUTE RENAL FAILUREACUTE KIDNEY INJURY / ACUTE RENAL FAILURE
ACUTE KIDNEY INJURY / ACUTE RENAL FAILUREDennis Daniel
 
renal failure
renal failurerenal failure
renal failureRia Saira
 
Acute renal failure(Emergency Medicine)
Acute renal failure(Emergency Medicine)Acute renal failure(Emergency Medicine)
Acute renal failure(Emergency Medicine)kalyan ram
 
Nephrotic syndrome
Nephrotic syndrome Nephrotic syndrome
Nephrotic syndrome Abhay Mange
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failureJijo G John
 
Acute renal failure 2018
Acute renal failure 2018Acute renal failure 2018
Acute renal failure 2018BMCStudents
 
Acute and Chronic Renal Failure
Acute and Chronic Renal FailureAcute and Chronic Renal Failure
Acute and Chronic Renal FailureMalarvannan_mv04
 
Chronic Renal Failure (UG)
Chronic Renal Failure (UG)Chronic Renal Failure (UG)
Chronic Renal Failure (UG)Dr Ashutosh Ojha
 
Management of Chronic Kidney Disorder (CKD)
Management of Chronic Kidney Disorder (CKD)Management of Chronic Kidney Disorder (CKD)
Management of Chronic Kidney Disorder (CKD)Sharanya Rajan
 

What's hot (20)

Management of ckd
Management of ckdManagement of ckd
Management of ckd
 
Acute renal failure
Acute renal failure Acute renal failure
Acute renal failure
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
Pathophysiology of liver cirrhosis and alcholoic liver disease
Pathophysiology of liver cirrhosis and alcholoic liver diseasePathophysiology of liver cirrhosis and alcholoic liver disease
Pathophysiology of liver cirrhosis and alcholoic liver disease
 
Acute kidney injury defnition, causes,
Acute kidney injury   defnition, causes,Acute kidney injury   defnition, causes,
Acute kidney injury defnition, causes,
 
ACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENTACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENT
 
ACUTE KIDNEY INJURY / ACUTE RENAL FAILURE
ACUTE KIDNEY INJURY / ACUTE RENAL FAILUREACUTE KIDNEY INJURY / ACUTE RENAL FAILURE
ACUTE KIDNEY INJURY / ACUTE RENAL FAILURE
 
Hyponatremia
HyponatremiaHyponatremia
Hyponatremia
 
renal failure
renal failurerenal failure
renal failure
 
Acute renal failure(Emergency Medicine)
Acute renal failure(Emergency Medicine)Acute renal failure(Emergency Medicine)
Acute renal failure(Emergency Medicine)
 
Nephrotic syndrome
Nephrotic syndrome Nephrotic syndrome
Nephrotic syndrome
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
Pyelonephritis
PyelonephritisPyelonephritis
Pyelonephritis
 
Renal stones
Renal stonesRenal stones
Renal stones
 
Acute renal failure 2018
Acute renal failure 2018Acute renal failure 2018
Acute renal failure 2018
 
Chronic Kidney Disease
Chronic Kidney DiseaseChronic Kidney Disease
Chronic Kidney Disease
 
Acute and Chronic Renal Failure
Acute and Chronic Renal FailureAcute and Chronic Renal Failure
Acute and Chronic Renal Failure
 
Chronic Renal Failure (UG)
Chronic Renal Failure (UG)Chronic Renal Failure (UG)
Chronic Renal Failure (UG)
 
Management of Chronic Kidney Disorder (CKD)
Management of Chronic Kidney Disorder (CKD)Management of Chronic Kidney Disorder (CKD)
Management of Chronic Kidney Disorder (CKD)
 
Renal failure-ARF & CRF
Renal failure-ARF & CRFRenal failure-ARF & CRF
Renal failure-ARF & CRF
 

Viewers also liked

Pathophysiology of acute kidney injury
Pathophysiology of acute kidney injuryPathophysiology of acute kidney injury
Pathophysiology of acute kidney injurySnehasis Ghosh
 
Injuria renal aguda
Injuria renal agudaInjuria renal aguda
Injuria renal agudaRaul Porras
 
Insuficiencia renal aguda 2013
Insuficiencia renal aguda 2013Insuficiencia renal aguda 2013
Insuficiencia renal aguda 2013Luis Soliz
 
Fisiopatología de la insuficiencia renal aguda
Fisiopatología de la insuficiencia renal agudaFisiopatología de la insuficiencia renal aguda
Fisiopatología de la insuficiencia renal agudaHanssel
 
Insuficiencia renal aguda - I.R.A.
Insuficiencia renal aguda - I.R.A.Insuficiencia renal aguda - I.R.A.
Insuficiencia renal aguda - I.R.A.Shelby Perez
 
Insuficiencia renal aguda
Insuficiencia renal agudaInsuficiencia renal aguda
Insuficiencia renal agudakaren reyes
 
Insuficiencia Renal Aguda
Insuficiencia Renal AgudaInsuficiencia Renal Aguda
Insuficiencia Renal AgudaHome
 
Insuficiencia renal aguda diapositivas
Insuficiencia renal aguda diapositivasInsuficiencia renal aguda diapositivas
Insuficiencia renal aguda diapositivasVictor Mendoza
 

Viewers also liked (11)

Pathophysiology of acute kidney injury
Pathophysiology of acute kidney injuryPathophysiology of acute kidney injury
Pathophysiology of acute kidney injury
 
Injuria renal aguda
Injuria renal agudaInjuria renal aguda
Injuria renal aguda
 
Insuficiencia renal aguda 2013
Insuficiencia renal aguda 2013Insuficiencia renal aguda 2013
Insuficiencia renal aguda 2013
 
Fisiopatología de la insuficiencia renal aguda
Fisiopatología de la insuficiencia renal agudaFisiopatología de la insuficiencia renal aguda
Fisiopatología de la insuficiencia renal aguda
 
LESION RENAL AGUDA 2016
LESION RENAL AGUDA  2016LESION RENAL AGUDA  2016
LESION RENAL AGUDA 2016
 
Insuficiencia renal aguda - I.R.A.
Insuficiencia renal aguda - I.R.A.Insuficiencia renal aguda - I.R.A.
Insuficiencia renal aguda - I.R.A.
 
Insuficiencia renal aguda
Insuficiencia renal agudaInsuficiencia renal aguda
Insuficiencia renal aguda
 
Insuficiencia Renal Aguda.ppt
Insuficiencia Renal Aguda.pptInsuficiencia Renal Aguda.ppt
Insuficiencia Renal Aguda.ppt
 
Insuficiencia Renal Aguda
Insuficiencia Renal AgudaInsuficiencia Renal Aguda
Insuficiencia Renal Aguda
 
Insuficiencia Renal Aguda
Insuficiencia Renal AgudaInsuficiencia Renal Aguda
Insuficiencia Renal Aguda
 
Insuficiencia renal aguda diapositivas
Insuficiencia renal aguda diapositivasInsuficiencia renal aguda diapositivas
Insuficiencia renal aguda diapositivas
 

Similar to Acute renal failure (arf)

Acuterenalfailure2 130207032508-phpapp01
Acuterenalfailure2 130207032508-phpapp01Acuterenalfailure2 130207032508-phpapp01
Acuterenalfailure2 130207032508-phpapp01paulmanthi
 
Approach to Acute renal failure.ppt
Approach to Acute renal failure.pptApproach to Acute renal failure.ppt
Approach to Acute renal failure.pptvictor431494
 
Renoprotective anesthesia
Renoprotective anesthesiaRenoprotective anesthesia
Renoprotective anesthesiaVkas Subedi
 
1 Acute Kidney Injury.pptx
1 Acute Kidney Injury.pptx1 Acute Kidney Injury.pptx
1 Acute Kidney Injury.pptxSani42793
 
Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury AIIMS, New Delhi, India
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injurydrriyaz95
 
best Ckd presentation1 by Dr. sachin kr rana
best Ckd presentation1  by Dr. sachin kr ranabest Ckd presentation1  by Dr. sachin kr rana
best Ckd presentation1 by Dr. sachin kr ranaSachin Rana
 
Clinical pharmacy in Nephrology
Clinical pharmacy in NephrologyClinical pharmacy in Nephrology
Clinical pharmacy in NephrologyEneutron
 
Renal Review.ppt
Renal Review.pptRenal Review.ppt
Renal Review.pptAJAY MANDAL
 
acuterenalfailure-.pptx
acuterenalfailure-.pptxacuterenalfailure-.pptx
acuterenalfailure-.pptxbhavanibb
 
Acute renal failure lecture notes
Acute renal failure lecture notesAcute renal failure lecture notes
Acute renal failure lecture notesEazzy MD
 
N2100 renal lecture spring 2014 voice over
N2100 renal lecture spring 2014 voice overN2100 renal lecture spring 2014 voice over
N2100 renal lecture spring 2014 voice overRobinAustin12
 
Portal hypertension, liver cirrhosis
Portal hypertension, liver cirrhosisPortal hypertension, liver cirrhosis
Portal hypertension, liver cirrhosisPatinya Yutchawit
 
RENAL EMERGENCIES.pptx
RENAL EMERGENCIES.pptxRENAL EMERGENCIES.pptx
RENAL EMERGENCIES.pptxShubhamgaur95
 

Similar to Acute renal failure (arf) (20)

Acuterenalfailure2 130207032508-phpapp01
Acuterenalfailure2 130207032508-phpapp01Acuterenalfailure2 130207032508-phpapp01
Acuterenalfailure2 130207032508-phpapp01
 
Approach to Acute renal failure.ppt
Approach to Acute renal failure.pptApproach to Acute renal failure.ppt
Approach to Acute renal failure.ppt
 
Aki
AkiAki
Aki
 
Acute renal failure (2)
Acute renal failure (2)Acute renal failure (2)
Acute renal failure (2)
 
Renoprotective anesthesia
Renoprotective anesthesiaRenoprotective anesthesia
Renoprotective anesthesia
 
Renal Revision
Renal RevisionRenal Revision
Renal Revision
 
AKI
AKIAKI
AKI
 
1 Acute Kidney Injury.pptx
1 Acute Kidney Injury.pptx1 Acute Kidney Injury.pptx
1 Acute Kidney Injury.pptx
 
Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury
 
AKI - Approach
AKI - ApproachAKI - Approach
AKI - Approach
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
best Ckd presentation1 by Dr. sachin kr rana
best Ckd presentation1  by Dr. sachin kr ranabest Ckd presentation1  by Dr. sachin kr rana
best Ckd presentation1 by Dr. sachin kr rana
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
Clinical pharmacy in Nephrology
Clinical pharmacy in NephrologyClinical pharmacy in Nephrology
Clinical pharmacy in Nephrology
 
Renal Review.ppt
Renal Review.pptRenal Review.ppt
Renal Review.ppt
 
acuterenalfailure-.pptx
acuterenalfailure-.pptxacuterenalfailure-.pptx
acuterenalfailure-.pptx
 
Acute renal failure lecture notes
Acute renal failure lecture notesAcute renal failure lecture notes
Acute renal failure lecture notes
 
N2100 renal lecture spring 2014 voice over
N2100 renal lecture spring 2014 voice overN2100 renal lecture spring 2014 voice over
N2100 renal lecture spring 2014 voice over
 
Portal hypertension, liver cirrhosis
Portal hypertension, liver cirrhosisPortal hypertension, liver cirrhosis
Portal hypertension, liver cirrhosis
 
RENAL EMERGENCIES.pptx
RENAL EMERGENCIES.pptxRENAL EMERGENCIES.pptx
RENAL EMERGENCIES.pptx
 

More from Mohit Aggarwal

Autoimmune hepatitis better understanding (2)
Autoimmune hepatitis better understanding (2)Autoimmune hepatitis better understanding (2)
Autoimmune hepatitis better understanding (2)Mohit Aggarwal
 
Autoimmune hepatitis rajesh
Autoimmune hepatitis rajeshAutoimmune hepatitis rajesh
Autoimmune hepatitis rajeshMohit Aggarwal
 
Arterial blood gas analysis in clinical practice (2)
Arterial blood gas analysis in clinical practice (2)Arterial blood gas analysis in clinical practice (2)
Arterial blood gas analysis in clinical practice (2)Mohit Aggarwal
 
Approach to-a-patient-with-chronic-diarrhoea (7)
Approach to-a-patient-with-chronic-diarrhoea (7)Approach to-a-patient-with-chronic-diarrhoea (7)
Approach to-a-patient-with-chronic-diarrhoea (7)Mohit Aggarwal
 
Approach to the_patient_with_myopathy
Approach to the_patient_with_myopathyApproach to the_patient_with_myopathy
Approach to the_patient_with_myopathyMohit Aggarwal
 
Approach to pituitary_tumours
Approach to pituitary_tumoursApproach to pituitary_tumours
Approach to pituitary_tumoursMohit Aggarwal
 
Approach to a_case_of_headache
Approach to a_case_of_headacheApproach to a_case_of_headache
Approach to a_case_of_headacheMohit Aggarwal
 
Approach to a patient with vasculitis and its
Approach to a patient with vasculitis and itsApproach to a patient with vasculitis and its
Approach to a patient with vasculitis and itsMohit Aggarwal
 
Approach to a patient with positive ana levels (2)
Approach to a patient with positive ana levels (2)Approach to a patient with positive ana levels (2)
Approach to a patient with positive ana levels (2)Mohit Aggarwal
 
Approach to a patient with hyponatremia (2) (1)
Approach to a patient with hyponatremia (2) (1)Approach to a patient with hyponatremia (2) (1)
Approach to a patient with hyponatremia (2) (1)Mohit Aggarwal
 
Approach and management of chronic kidney disease sandeep
Approach and management of chronic kidney disease sandeepApproach and management of chronic kidney disease sandeep
Approach and management of chronic kidney disease sandeepMohit Aggarwal
 
Antithrombotic in difficul clinical condition umesh
Antithrombotic in difficul clinical condition  umeshAntithrombotic in difficul clinical condition  umesh
Antithrombotic in difficul clinical condition umeshMohit Aggarwal
 
Antibiotic choice in icu 20.10.04 final
Antibiotic choice in icu 20.10.04 finalAntibiotic choice in icu 20.10.04 final
Antibiotic choice in icu 20.10.04 finalMohit Aggarwal
 
Anatomyofposteriortibialnervebyim 130629043516-phpapp01
Anatomyofposteriortibialnervebyim 130629043516-phpapp01Anatomyofposteriortibialnervebyim 130629043516-phpapp01
Anatomyofposteriortibialnervebyim 130629043516-phpapp01Mohit Aggarwal
 

More from Mohit Aggarwal (20)

Autoimmune hepatitis better understanding (2)
Autoimmune hepatitis better understanding (2)Autoimmune hepatitis better understanding (2)
Autoimmune hepatitis better understanding (2)
 
Autoimmune hepatitis rajesh
Autoimmune hepatitis rajeshAutoimmune hepatitis rajesh
Autoimmune hepatitis rajesh
 
Asd and vsd
Asd and vsdAsd and vsd
Asd and vsd
 
Arterial blood gas analysis in clinical practice (2)
Arterial blood gas analysis in clinical practice (2)Arterial blood gas analysis in clinical practice (2)
Arterial blood gas analysis in clinical practice (2)
 
Ards
ArdsArds
Ards
 
Approachto cp
Approachto cpApproachto cp
Approachto cp
 
Approach to-a-patient-with-chronic-diarrhoea (7)
Approach to-a-patient-with-chronic-diarrhoea (7)Approach to-a-patient-with-chronic-diarrhoea (7)
Approach to-a-patient-with-chronic-diarrhoea (7)
 
Approach to the_patient_with_myopathy
Approach to the_patient_with_myopathyApproach to the_patient_with_myopathy
Approach to the_patient_with_myopathy
 
Approach to pituitary_tumours
Approach to pituitary_tumoursApproach to pituitary_tumours
Approach to pituitary_tumours
 
Approach to a_case_of_headache
Approach to a_case_of_headacheApproach to a_case_of_headache
Approach to a_case_of_headache
 
Approach to a patient with vasculitis and its
Approach to a patient with vasculitis and itsApproach to a patient with vasculitis and its
Approach to a patient with vasculitis and its
 
Approach to a patient with positive ana levels (2)
Approach to a patient with positive ana levels (2)Approach to a patient with positive ana levels (2)
Approach to a patient with positive ana levels (2)
 
Approach to a patient with hyponatremia (2) (1)
Approach to a patient with hyponatremia (2) (1)Approach to a patient with hyponatremia (2) (1)
Approach to a patient with hyponatremia (2) (1)
 
Approach and management of chronic kidney disease sandeep
Approach and management of chronic kidney disease sandeepApproach and management of chronic kidney disease sandeep
Approach and management of chronic kidney disease sandeep
 
Aphasia nikhil
Aphasia nikhilAphasia nikhil
Aphasia nikhil
 
Aortic regurgitation
Aortic regurgitationAortic regurgitation
Aortic regurgitation
 
Antithrombotic in difficul clinical condition umesh
Antithrombotic in difficul clinical condition  umeshAntithrombotic in difficul clinical condition  umesh
Antithrombotic in difficul clinical condition umesh
 
Antibiotic choice in icu 20.10.04 final
Antibiotic choice in icu 20.10.04 finalAntibiotic choice in icu 20.10.04 final
Antibiotic choice in icu 20.10.04 final
 
Andropause
AndropauseAndropause
Andropause
 
Anatomyofposteriortibialnervebyim 130629043516-phpapp01
Anatomyofposteriortibialnervebyim 130629043516-phpapp01Anatomyofposteriortibialnervebyim 130629043516-phpapp01
Anatomyofposteriortibialnervebyim 130629043516-phpapp01
 

Recently uploaded

Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerunnathinaik
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 

Recently uploaded (20)

Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developer
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 

Acute renal failure (arf)

  • 1. CHAIRPERSON – DR. SANJEEV KUMAR SPEAKER - DR. ASHISH KUMAR
  • 2. DEFINITION  AKI is a sudden and usually reversible decrease in the glomerular filtration rate (GFR) occurring over a period of hours to days.  The term “Acute Kidney Injury” now replaces the term ARF; the term Acute Renal Failure should now be restricted to patients who have AKI and “need renal replacement therapy”.
  • 3. ‘ACUTE KIDNEY INJURY’ Abrupt reduction [<48 hrs] in kidney function, defined as an absolute increase in S creatinine of ≥0.3 mg/dL A percentage increase in S creatinine of ≥ 50% [1.5 fold from baseline] or a reduction in urine output-- documented oliguria of < 0.5 ml/kg/hr, for more than six hours.
  • 4.
  • 5.
  • 6. Hilton, R. BMJ 2006;333:786-790 CAUSES OF ACUTE KIDNEY INJURY AKI
  • 7. Pre-renal causes of AKI – Volume depletion • Renal losses (diuretics, polyuria) • GI losses (vomiting, diarrhea) • Cutaneous losses (burns, Stevens-Johnson syndrome) • Hemorrhage • Pancreatitis – Decreased cardiac output • Heart failure • Pulmonary embolus • Acute myocardial infarction • Severe valvular heart disease
  • 8. Post-renal causes of AKI – Ureteric obstruction • Stone disease, • Tumor, • Fibrosis, • Ligation during pelvic surgery – Bladder neck obstruction • Benign prostatic hypertrophy [BPH] • Cancer of the prostate • Neurogenic bladder • Drugs(Tricyclic antidepressants, ganglion blockers, • Bladder tumor, • Stone disease, hemorrhage/clot) – Urethral obstruction (strictures, tumor)
  • 9. Renal Causes of AKI • Large Vascular • Small vascular and Glomerular • Interstitial nephritis • Acute tubular necrosis
  • 10. Renal Causes of AKI • Large Vascular • Renovasc disease + ACEI • Renal artery thrombosis/dissection • Cholersterol emboli (recent Cardiac cath/aortic surgery) • Renal vein Thrombosis (hypercoagulable, Nephrotic)
  • 11. • Acute Glomerulonephritis (GN) / Small vascular • Anti–glomerular basement membrane (GBM) disease (Goodpasture syndrome) • Anti–neutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-associated GN) (Wegener granulomatosis, microscopic polyangiitis) • Immune complex GN (lupus, postinfectious, cryoglobulinemia, primary membranoproliferative glomerulonephritis) • IgA nephropathy • HUS/TTP • Malignant hypertension
  • 12. • Tubular • Ischemic • Toxic – Heme pigment (rhabdomyolysis, intravascular hemolysis) – Crystals (tumor lysis syndrome, seizures, ethylene glycol poisoning, megadose vitamin C, acyclovir, indinavir, methotrexate) – Drugs (aminoglycosides, lithium, amphotericin B, pentamidine, cisplatin, ifosfamide, radiocontrast agents)
  • 13. • Interstitial • Drugs (penicillins, cephalosporins, NSAIDs, proton-pump inhibitors, allopurinol, rifampin, indinavir, mesalamine, sulfonamides) • Infection (pyelonephritis, viral nephritis) • Systemic disease (Sjogren syndrome, sarcoid, lupus, lymphoma, leukemia )
  • 14. Pre-renal AKI • History -- blood or volume loss -- cardiac failure, arrhythmia, (cardiogenic shock) -- sepsis • Physical exam – focus on volume status – Vital signs – current and preceding the development of AKI – Neck veins, lungs, heart, mucous membranes and edema
  • 15. Pre-renal AKI • There is no intrinsic kidney damage in pre-renal AKI; rising BUN and creat occur because the kidneys are inadequately perfused. • Therefore, normal renal physiologic responses occur, manifested in urine electrolytes that reflect intact renal tubular function.
  • 16. Pre-renal AKI • Intact renal tubular function in the setting of impaired renal perfusion results in avid tubular reabsorption of sodium. • Therefore, low urine Na (<20 mEq/L) and low fractional excretion of Na (<1%) and of urea (<35%) in pre-renal ARF.
  • 17.
  • 18. Pre-renal AKI • Laboratory studies – BUN:creatinine ratio – elevated in pre-renal; >20:1 – Urine sediment: hyaline and fine granular casts – Urine Specific gravity: high – Urine dipstick: negative (no blood or protein) – Urinary to plasma creatinine ratio: high – Urinary Na: low – FENa: low
  • 19. • Sustained prerenal azotemia is the main factor that predisposes patients to ischemia- induced acute tubular necrosis (ATN) • Prerenal azotemia and ischemic tubular necrosis represent a continuum. Azotemia progresses to necrosis when blood flow is sufficiently compromised to result in the death of tubular cells. • Most cases of ischemic AKI are reversible if the underlying cause is corrected.
  • 20. Renal or Intrinsic AKI • In all types of intrinsic AKI, BUN:creat ratio preserved (10-20:1) • The history, P/E, and especially urine analysis will help to differentiate
  • 21. Renal or Intrinsic ARF – Vascular Type • Large vessels – must be bilateral – Renal vein thrombosis – Renal artery stenosis • Small vessels – Vasculitis – Atheroembolic – Malignant hypertension – Thrombotic microangiopathies (HUS/TTP)
  • 22. Renal or Intrinsic AKI – Glomerular • History – systemic or primary kidney • P/E – BP (usually hypertensive) -- edema • BUN:creatinine ratio: preserved • Urine analysis : + protein, blood RBCs,+ • Often require kidney biopsy RBC Casts
  • 23. Renal or Intrinsic AKI – Interstitial • History – exposure to medications usually 7- 14 days earlier -- penicillins, cephalosporins, dilantin • P/E – maculopapular erythematous skin rash -- 1/3 have fever, arthralgias • BUN:creatinine ratio: 10-20:1 • Urine analysis: + protein, blood WBCs, WBC casts, eosinophils
  • 24. Renal or Intrinsic ATN – Acute Tubular Necrosis • The most common type of hospital-acquired ARF • May be 1) ischemic or 2) nephrotoxic in etiology • Most common ATN is ischemic, most often due to a prolonged pre-renal state (prolonged reduced renal perfusion)
  • 25.
  • 26. Renal or Intrinsic ATN – Acute Tubular Necrosis • History – prolonged pre-renal state -- exposure to nephrotoxin aminoglycoside antibiotics ethylene glycol pigments (myoglobin, hemoglobin) • P/E – assess volume status (to exclude pre- renal AKI)
  • 27. Renal or Intrinsic ATN – Acute Tubular Necrosis • BUN:creatinine ratio: preserved (10-20:1) • Urine analysis : negative protein, blood -- granular casts (dirty brown casts) -- renal tubular epithelial cells • Urine chemistries – Urinary Na: high (>40 meq/L) FENa: high (>2%) Urinary to plasma creatinine ratio: low
  • 28. Contrast-Induced AKI Prevalence • Less than 1% in patients with normal renal function • Increases significantly with renal insufficiency Risk factors • Renal insufficiency • Diabetes mellitus • Multiple myeloma • High osmolar (ionic) contrast media • Contrast medium volume
  • 29. Contrast-induced AKI Clinical Characteristics • Onset - 24 to 48 hrs after exposure • Duration - 5 to 7 days • Non-oliguric (majority) • Dialysis - rarely needed • Urinary sediment - variable • FENa: Low
  • 30. Contrast-induced AKI Prophylatic Strategies • Use I.V. contrast only when necessary • Hydration • Minimize contrast volume • Low-osmolar (nonionic) contrast media
  • 31. Post-Renal AKI • Elevated pressure in urinary conduits results in renal parenchymal destruction if unrelieved • important to rule out quickly: – potential for recovery of renal function is often inversely related to the duration of the obstruction
  • 32. Post-Renal AKI • History – symptoms (frequency, hesitancy, etc) -- carcinoma, DM, stones, medications • P/E – distended bladder, prostatic enlargement, pelvic masses , lymph nodes • Laboratory studies-- elevated BUN:creat ratio -- unremarkable urine sediment -- variable urine chemistries • Renal ultrasound – hydronephrosis • Treatment is to relieve the obstruction – Bladder catheterization – Nephrostomy tubes
  • 33. AKI: URINE VOLUME • Anuria (< 100 ml/24h) – Acute bilateral arterial or venous occlusion – Bilateral cortical necrosis – Acute necrotizing glomerulonephritis – Obstruction (complete) – ATN (very rare) • Oliguria (100-500 ml/24h) – Pre-renal azotemia – ATN • Non-Oliguria (> 500 ml/24h) – ATN – Obstruction (partial)
  • 34. INVESTIGATIONS Biochemistry  Blood urea,  creatinine,  electrolytes,  Blood gas analysis.  Urine osmolality/sodium/creatinine
  • 35. Serum Creatinine as a marker for AKI and GFR  Normal S.Creatinine is 0.6-1.2mg/dl and is the most commonly used parameter to assess renal function.  Unfortunately the correlation between S.Creatinine concentration and GFR may be confounded by several factors.
  • 36. There is abrupt drop in GFR but the S.Cr. does not start going up for 24 or 36 hours after the acute insult . 40 80 0 GFR (mL/min) 0 7 14 21 28 4 Days 2 0 6 Serum Creatinine (mg/dL) Relationship between GFR and serum creatinine in AKI
  • 37. Creatinine is not an ideal marker 1.Creatinine excretion is dependent on renal factors independent of function: – Certain medications such as cimetidine and trimethoprim interfere with proximal tubular creatinine secretion and may cause rise in S. creatinine without fall in GFR.
  • 38. 2. S.Creatinine is dependent on nonrenal factors independent of renal function  S.Creatinine is dependent on muscle mass, infection, volume of distribution, age, gender, race, body habitus, diet, presence of amputations.  Eg. S. Creatinine of 1.2mg/dl in a 40kg elderly signifies severe reduction of GFR while the same value in a 100kg represents a normal renal function 3. Creatinine production and excretion must be in a steady state before creatinine may be used in any formula for the estimation of GFR.
  • 39. Fractional Excretion of Na • Since urinary indices depend on urine sodium concentration, they should be interpreted cautiously if the patient has received diuretic  Spot urine Na may be affected (raised) by diuretic use and baseline impaired kidney function (CKD where maximum urine Na reabsorption is impaired)  Fractional excretion of Na accounts for this by including creatinine: FxExNa = urine [Na] ÷ plasma [Na] X 100 urine creatinine ÷ plasma creatinine
  • 40. RENAL INDICES • Renal Failure Index (RFI) RFI = urine [Na] urine creatinine /serum creatinine
  • 41. URINE AND SERUM LABORATORY VALUES Prenal Renal BUN/Cr >20 <20 FeNa <1% >1% RFI <1% >1% UNa (mEq/L) <20 > 40 Specific gravity high low Pre-renal
  • 42. URINE ANALYSIS • Dipstick for blood, protein – Suggests a renal inflammatory process • Microscopy may show cells, casts, crystals
  • 43. RBCs in Urine Present in glomerulonephritis , vasculitis , HUS TTP scleroderma crisis
  • 44. URINARY CASTS  Hyaline –prerenal ARF  Granular –ATN (muddy brown)  Red blood cell casts –glomerulonephritis,vasculitis malignant hypertension  WBC casts- AIN, pyelonephritis ,leukemic or lymphomatous infiltrates
  • 45. Red Blood Cell Cast • Two examples of red blood cell casts, typical of glomerular bleeding.
  • 47. Pigmented Granular Casts • Pigmented granular (“muddy brown”) casts are characteristic of acute tubular necrosis
  • 48. Crystals • Urate crystals – acute urate nephropathy • Oxalate crystals –ethylene glycol ingestion /acyclovir/ indinavir • Eosinophiluria  > 5 % of WBC s AIN ,atherothrombotic disease
  • 49. Haematology • Full blood count, blood film: – Eosinophilia may be present in acute interstitial nephritis, cholesterol embolization, or vasculitis (CSS) – Thrombocytopenia and red cell fragments suggest thrombotic microangiopathy –TTP, HUS • Coagulation studies – Disseminated intravascular coagulation associated with sepsis
  • 50. Immunology  Antinuclear antibody (ANA) , Anti-double stranded (ds) antibody -  ANA positive in SLE and other autoimmune disorders;DNA antibodies anti-ds DNA antibodies more specific for SLE  C3 & C4 complement concentrations-  Low in SLE, acute post infectious glomerulonephritis, Cryoglobulinemia  ASO and anti-DNAse B titres  High after streptococcal infection
  • 51. Immunology... • ANCA • p-ANCA - Anti PR3 antibodies • c-ANCA - Anti MPO antibodies – Associated with systemic vasculitis - Wegener’s granulomatosis; Microscopic polyangiitis. • AntiGBM antibodies – Present in Goodpasture’s disease
  • 52. Serology • Hepatitis B and C, HIV serology
  • 53. Radiology • Renal ultrasonography : For renal size, symmetry, evidence of obstruction • Pyelography : localization • MRA/ Doppler US : arterial /venous obstruction
  • 54. NEW MARKER • Cystatin C –protein Produced by nucleated cells Filtered and completely reabsorbed Changes in serum levels occur sooner
  • 55. NOVEL BIOMARKERS • 1. IL- 18 • 2.KIM-1 • 3.Gro α/KC • 4.NGAL-neutrophil gelatinase associated lipocalin • 5.NHE-3 -Sodium–hydrogen antiporter 3
  • 59. Other Complications Hyperuricemia Infection- pneumonia, sepsis Git- nausea, vomiting, malnutrition, git bleeding CNS- asterixis, mental changes, seizures Uremic syndrome
  • 60. AKI: PREVENTION Recognize patients at risk (postoperative states, cardiac surgery, septic shock) Prevent progression from prerenal to renal Preserve renal perfusion(isovolemia, cardiac output, normal blood pressure) Avoid nephrotoxins (aminoglycosides, NSAIDS, amphotericin)
  • 61. GENERAL PROTOCOL FOR MANAGEMENT OF AKI • Treat the underlying disease • Strictly monitor intake and output (weight, urine output, insensible losses, IVF) • Monitor serum electrolytes • Adjust medication dosages according to GFR • Avoid highly nephrotoxic drugs • Attempt to convert oliguric to non-oliguric renal failure (furosemide)
  • 62. FLUID THERAPY If patient is fluid overloaded • fluid restriction (insensible losses) • attempt furosemide 1-2 mg/kg • Renal replacement therapy If patient is dehydrated: • restore intravascular volume first • then treat as euvolemic If patient is euvolemic: • restrict to insensible losses (30-35 ml/100kcal/24 hours) + other losses (urine, chest tubes, etc)
  • 63. SODIUM • Most patients have dilutional hyponatremia which should be treated with fluid restriction • Severe hyponatremia (Na< 125 mEq/L) : dialysis or hemofiltration
  • 64. POTASSIUM • Oliguric renal failure is often complicated by hyperkalemia, increasing the risk of cardiac arrhythmias • Treatment of hyperkalemia: – sodium bicarbonate (1-2 mEq/kg) – insulin + hypertonic dextrose – sodium polystyrene : 1 gm/kg . (Hypernatremia and hypertension are potential complications) – dialysis
  • 65. MANAGEMENT OF AKI  Metabolic acidosis – soda bicarb ., if < 15 meq  Hyperphosphatemia – PO4 binders –sevalamer  Hypocalcemia –calcium carbonate  Nutrition –restriction of dietary protein < 0.8 g/kg /d calories – 25-30 kcal /kg/d enteral nutrition preferred
  • 66. Criteria for Initiation of RRT Anuria Oliguria Pulmonary edema Hyperkalemia >6.5mmol/L Severe acidemia <7.2 Uremic encephalopathy Uremic pericarditis